HIV and Africa's elderly: The problems and possibilities

AIDS

Volumn 26, Issue SUPPL.1, 2012, Pages

  Bendavid, Eran ^a   Ford, Nathan ^b,c   Mills, Edward J ^d  

^a STANFORD UNIVERSITY   (United States)

^b Medecins Sans Frontiers   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

aging; antiretroviral access; co morbidities; elderly; polypill

Indexed keywords

AFRICA; ANUS CANCER; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COMORBIDITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; KAPOSI SARCOMA; LIFE EXPECTANCY; MENTAL DISEASE; MORBIDITY; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

AFRICA SOUTH OF THE SAHARA; AGED; AGING; ANTI-HIV AGENTS; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASMS; OSTEOPOROSIS; PREVALENCE; SENTINEL SURVEILLANCE;

EID: 84863828028     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283558513     Document Type: Article

References (58)

1. UN Population Division. World population prospects: the 2010 revision. 1 September 2011. http://esa.un.org/wpp/Documenta tion/WPP2010-ASSUMPTIONS-AND- VARIANTS.pdf and http://esa.un.org/wpp/. [Accessed 31 August 2011]
2. Rajaratnam JK, Marcus JR, Levin-Rector A, Chalupka AN, Wang H, Dwyer L, et al. Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet 2010; 375:1704-1720.
3. Data in Gapminder World. http://www.gapminder.org/data/. [Accessed 7 January 2012]
4. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS, 2010.
5. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011; 155:209-216.
6. Cohen B, Menken JA. Aging in sub-Saharan Africa: recommendations for furthering research. Washington, DC: national Academies Press; 2006.
7. World Health Organization. Health statistics and health information systems. Definition of an older or elderly person. http://www.who.int/ healthinfo/survey/ageingdefnolder/en/index. html. [Accessed 7 January 2012]
8. Boerma JT, Ghys PD, Walker N. Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet 2003; 362:1929-1931. (Pubitemid 37518513)
9. Walker N, Grassly NC, Garnett GP, Stanecki KA, Ghys PD. Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet 2004; 363:2180-2185. (Pubitemid 38844162)
10. Shisana O, Council HSR, Centre for AIDS Development R, Evaluation, Council SAMR, Diseases NIfC. South African national HIV prevalence, incidence, behaviour and communication survey, 2008: A turning tide among teenagers? Cape Town: HSRC Press; 2009.
11. Shisana O, Simbayi L. South African national HIV prevalence, HIV incidence, behaviour and communication survey, 2005. Cape Town: Sciences Research Council; 2006.
12. Kenya AIDS Indicator Survey 2007. Nairobi Kenya: National AIDS and STI Control Programme, Ministry of Health Kenya (NASCOP); 2008.
13. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, Muhwava W, et al. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 2008; 37:956.
14. Kahn K, Tollman SM, Collinson MA, Clark SJ, Twine R, Clark BD, et al. Research into health, population and social transitions in rural South Africa: data and methods of the Agincourt Health and Demographic Surveillance System. Scand J Public Health 2007; 35:8-20. (Pubitemid 47241575)
15. Glynn JR, Buvé A, Caraël M, Musonda RM, Kahindo M, Macauley I, et al. Factors influencing the difference in HIV prevalence between antenatal clinic and general population in sub-Saharan Africa. AIDS 2001; 15:1717.
16. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ 2010; 88:847-853.
17. Greig J, Carrillo Casas E, O'Brien D, Mills EJ, Ford N. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries in sub-Saharan Africa. AIDS 2012.
18. Bakanda C, Birungi J, Mwesigwa R, Ford N, Cooper CL, Au-Yeung C, et al. Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy. AIDS 2011; 25:701.
19. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, Giddy J, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 2010; 24:2263.
20. Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 2004; 18:2029.
21. Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to
22. Sridhar D, Batniji R. Misfinancing global health: a case for transparency in disbursements and decision making. Lancet 2008; 372:1185-1191.
23. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352:48-62. (Pubitemid 40075680)
24. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21:1915.
25. Adler WH, Baskar PV, Chrest FJ, Dorsey-Cooper B, Winchurch RA, Nagel JE. HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient. Mech Ageing Dev 1997; 96:137-155. (Pubitemid 27279822)
26. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12:F51.
27. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423-1430.
28. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735. (Pubitemid 46658704)
29. Justice A, McGinnis K, Atkinson J. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS 2004; 18:S49-S59. (Pubitemid 38365906)
30. Hinkin C, Castellon S, Atkinson J. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol 2001; 54:S44-S52. (Pubitemid 34013689)
31. Lebowitz B, Pearson J, Schneider L. Diagnosis and treatment of depressionin late life. JAMA 1997; 278:1186-1190.
32. Horner M, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, et al. SEER cancer statistics review, 1975-2006. Bethesda, Maryland: National Cancer Institute; 2009.
33. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Atlanta, Georgia: for Disease Control and Prevention; 1992.
34. Dryden-Peterson S, Medhina H, Iwe N, Pusoentsi M, Avolos A, LaCasce A, et al. Malignancies among HIVRand HIV-Patients in a Prospective Cohort: Botswana. In: Proceedings of the Conference on Retroviruses and Opportunistic Infections Seattle; March 2012; P902.
35. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, et al. Bone mineral density and fractures in antiretroviralnaive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224 s, a substudy of ACTG A5202. J Infect Dis 2011; 203:1791.
36. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, et al. Accelerated bone mineral loss in HIVinfected patients receiving potent antiretroviral therapy. AIDS 2000; 14:F63-F67. (Pubitemid 30182458)
37. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 2003; 17:1917-1923. (Pubitemid 37070277)
38. Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S. Reduced bone density in HIV-infected women. AIDS 2004; 18:475-483. (Pubitemid 38365875)
39. Warming L, Hassager C, Christiansen C. Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 2002; 13:105-112. (Pubitemid 34241030)
40. Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Int Med 2003; 163:2187.
41. Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, et al. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS 2011; 25:1471-1479.
42. US Department of Health and Human Services. HIV/AIDS guidelines. 2012. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment- guidelines/0/.
43. Yusuf S. Two decades of progress in preventing vascular disease. Lancet 2002; 360:2-3. (Pubitemid 34756482)
44. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326:1419.
45. Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, et al. Effects of a polypill (Polycap) on risk factors in middleaged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009; 373:1341-1351.
46. Law MG. Cardiovascular complications of HIV: an overview of risk and a novel approach to prevention: the HIV polypill study. Curr Opin HIV AIDS 2006; 1:482-487.
47. Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012; 379:1591-1601.
48. Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and nonvascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379:1602-1612.
49. Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170255 patients from 76 randomized trials. QJM 2011; 104:109-124.
50. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65000 patients. J Am Coll Cardiol 2008; 52:1769-1781.
51. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
52. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.
53. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study. Clin Infect Dis 2011; 53:1130-1139.
54. Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, et al. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cô te d'Ivoire. Clin Infect Dis 2012; 54:714-723.
55. Thirumurthy H, Zivin JG, Goldstein M. The economic impact of AIDS treatment. J Hum Resources 2008; 43:511-552.
56. Bloom DE, Williamson JG. Demographic transitions and economic miracles in emerging Asia. World Bank Econ Rev 1998; 12:419-455. (Pubitemid 29198849)
57. World Development Indicators Online (WDI). www.databank.-worldbank.org/. [Accessed 14 October 2011]
58. Kautz T, Bendavid E, Bhattacharya J, Miller G. AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys. BMJ 2010; 340:c2841.